Francisco Javier
López Jiménez
Profesor/a Asociado/a en CC. de la Salud
Joaquín
Martínez López
Publicaciones en las que colabora con Joaquín Martínez López (7)
2024
-
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
Cancers, Vol. 16, Núm. 2
-
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression
Blood cancer journal, Vol. 14, Núm. 1, pp. 74
2023
-
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
Cancers, Vol. 15, Núm. 5
-
Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma
Journal of Thrombosis and Thrombolysis, Vol. 55, Núm. 3, pp. 464-473
2021
-
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study
Cancer Medicine, Vol. 10, Núm. 21, pp. 7629-7640
2014
-
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: Do we still need alkylators?
Blood, Vol. 124, Núm. 12, pp. 1887-1893
2012
-
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial
Blood, Vol. 120, Núm. 13, pp. 2581-2588